The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the ADDVISE GROUP AB B stock forecast from 0 analysts, the average analyst target price for ADDVISE GROUP AB B is not available over the next 12 months. ADDVISE GROUP AB B’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ADDVISE GROUP AB B is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, ADDVISE GROUP AB B’s stock price was EUR 0.4735. ADDVISE GROUP AB B’s stock price has changed by -20.95% over the past week, -24.36% over the past month and -56.64% over the last year.
No recent analyst target price found for ADDVISE GROUP AB B
No recent average analyst rating found for ADDVISE GROUP AB B
Company Overview ADDVISE GROUP AB B
ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The Lab business unit provides laboratory furnishings, ventilation, climate/clean rooms, and laboratory equipment to pharmaceutical and life science research industries. It is also involved in design, construction, and installation of clean rooms. The Healthcare business unit manufactures and supplies medical equipment and consumables for healthcare and pharmaceuticals. In addition, it manufactures and sells surgical tables, as well as offers cables, connectors, and wires. Further, the company develops orthopedic implants, stents for foot and ankle surgery, equipment, and software for monitoring patients, as well as operates online pharmacy. Additionally, it sells consumable materials for ultrasound systems, and examines for urology and gynecology. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden. Read Less
ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The Lab business unit provides laboratory furnishings, ventilation, climate/clean rooms, and laboratory equip...Read More
Frequently Asked Questions About ADDVISE GROUP AB B (Q3I:F) Stock
Stock Target Advisor's fundamental analysis for ADDVISE GROUP AB B's stock is Neutral.
Unfortunately we do not have enough data on Q3I:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on Q3I:F's stock to indicate what its average analyst target is.
Q3I:F stock's Price/Earning ratio is 12.90.
Our analysis grades Q3I:F stock's Price / Earning ratio at A-. This means that Q3I:F stock's Price/Earning ratio is above 9.999999999999998% of the stocks in the Medical Instruments & Supplies sector in the F exchange.
Based on this Q3I:F may be undervalued for its sector.
The last closing price of Q3I:F's stock was EUR 0.47.
The most recent market capitalization for Q3I:F is EUR 0.14B.
Unfortunately we do not have enough analyst data on Q3I:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ADDVISE GROUP AB B's stock.
As per our most recent records ADDVISE GROUP AB B has 620 Employees.
ADDVISE GROUP AB B's registered address is Grev Turegatan 30, Stockholm, Sweden, 114 38.
You can get more information about it from ADDVISE GROUP AB B's website at https://www.addvisegroup.se.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for Q3I:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
